drugset / Trial / NCT01432405
Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to examine the effect of exenatide, an anti-diabetes medication, on liver fat and blood levels of proteins that influence liver fat.
Timeline
- Start
- 2007-06
- Primary completion
- 2008-07
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exenatide | Peptide | 10 ug | Subcutaneous |
| Subject | Pioglitazone | Small molecule | 45 mg | Oral |